FDA warning-letter and enforcement intelligence delivered as a daily brief
Secure whistleblowing channel for EU Directive 2019/1937 compliance
Stage
Not given
Not given
Founded
Not given
2023
Based in
Not given
PL
Pricing model
Freemium
Paid
Pricing
Starter: free. Professional: $49/month. Enterprise: $199/month. Annual plans available at 20% discount. Payment via card (Polar or Lemon Squeezy) or crypto (USDT, USDC, SOL via xpayr). Cancel anytime.
Monthly: €60/month. Yearly: €41.67/month billed as €500/year. All features included, no per-employee fees. 30-day money-back guarantee on first paid subscription.
Key features
Filter by product type (device, drug, biologics, food, tobacco)
Company watchlists with instant notifications
Same-day alerts (Professional and Enterprise plans)
Searchable historical archive back to 2022
Email and Telegram delivery
CSV and API export
Customizable daily or weekly briefing schedule
API access and webhooks (Enterprise)
Slack and Teams delivery (Enterprise)
Multiple user seats (Enterprise)
Anonymous and confidential intake without account or company network required
Automatic 7-day acknowledgment and 3-month feedback deadline tracking
Secure two-way communication with encrypted messaging
PDF export with full message history, timeline and audit trail
Configurable data retention with automatic deletion
Automatic file metadata stripping to protect reporter anonymity
SAML single sign-on and SCIM 2.0 provisioning for identity integration
Whistleblowing channel available in 14 languages
Reports can be submitted by email or web form
What makes it different
Data normalized and classified from official FDA sources daily
Briefing designed to be scanned in 60 seconds
Precision filtering eliminates irrelevant alerts
Highest ROI for CDMO/CMO business development teams
No dashboard required—notification-only delivery
Published pricing with no per-employee fees or add-ons
Self-service deployment without implementation project or sales engagement
Report data hosted in EU with no loading through Cloudflare
Procurement evidence published including security gaps
Report content never sent to AI or large language models